TAM Receptors in Leukemia: Expression, Signaling, and Therapeutic Implications

Abstract excerpt

In the past 30 years there has been remarkable progress in the treatment of leukemia and lymphoma. However, current treatments are largely ineffective against relapsed leukemia and, in the case of pediatric patients, are often associated with severe long-term toxicities. Thus, there continues to be a critical need for the development of effective biologically targeted therapies. The TAM family of receptor...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apelin-related biomedical research
• Share to Phagocytosis and Immune Regulation